We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BMG LABTECH and InvivoSciences Initiate Market Collaboration
Product News

BMG LABTECH and InvivoSciences Initiate Market Collaboration

BMG LABTECH and InvivoSciences Initiate Market Collaboration
Product News

BMG LABTECH and InvivoSciences Initiate Market Collaboration


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "BMG LABTECH and InvivoSciences Initiate Market Collaboration"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BMG LABTECH, Inc. and InvivoSciences, Inc. have announced a strategic collaboration to market the time-dependent fluorescent assessment of engineered 3D heart tissues using advanced microplate reader technologies.

Employing an automated system, 3D heart tissues are fabricated with cardiomyocytes derived from human induced pluripotent stem cells.

The ultra- sensitive plate reader, CLARIOstar®, will analyze rapid beat-to-beat changes (up to 50 Hz) in the fluorescence intensities of dyes that indicate physiological states in engineered 3D heart tissue after drug/compound application.

In addition, InvivoSciences, Inc. is sponsoring a workshop during Cell Based Assays Summit in Munich Germany, December 02-04, 2013.

BMG LABTECH will have a short presentation at the workshop to discuss applications of microplate readers in cell and tissue based assays http://www.assayssummit.com/AgendaDay.aspx?tp_day=40163.

While on January 20th 2014, InvivoSciences and BMG LABTECH will be presenting a workshop tutorial at Society for Laboratory Automation and Screening (SLAS) in San Diego, CA.

These Workshops will highlight applications of pluripotent cells and engineered tissues in drug discovery, including disease model generation as well as personalized and regenerative medicine. Cost-effective and flexible approaches of pluripotent cell culture and its scale up procedures will be presented.

"InvivoSciences has established themselves as a leader in engineered 3D tissues using pluripotent stem cells," said E.J. Dell, Ph.D., International Marketing Director of BMG LABTECH. "We are pleased to partner with them to create a drug discovery platform that is biologically more relevant to researchers."

Ayla Annac, Co-founder and CEO of InvivoSciences comments, "We are especially proud and pleased to establish a long-term relationship with the leading developer and internationally-recognized manufacture of microplate readers, BMG LABTECH."

Advertisement